Ligand to Host Analyst Day on November 14th in Chicago
SAN DIEGO-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day in Chicago on Thursday, November 14, 2013 from 9:30 a.m. to 11:30 a.m. Central Time (7:30 a.m. to 9:30 a.m. Pacific Time). The event will feature presentations pertaining to the Company’s business and pipeline programs. The event will take place at the Drake Hotel at 140 East Walton Place, Chicago.
The presentations will be webcast live and can be accessed at www.ligand.com. A replay of this webcast will be available for 90 days following the event.
About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company focused on assembling a large portfolio of revenue generating assets through licensing and acquisition with the goal to generate sustainable cash-flow and profitability. Ligand has a diverse asset portfolio addressing the unmet medical needs of patients for a broad spectrum of diseases including thrombocytopenia, multiple myeloma, diabetes, hepatitis, muscle wasting, dyslipidemia, anemia and osteoporosis. Ligand’s Captisol platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Ligand has established multiple alliances with the world's leading pharmaceutical companies including GlaxoSmithKline, Onyx Pharmaceuticals, Merck, Pfizer, Baxter International, Bristol-Myers Squibb, Lundbeck Inc., Eli Lilly & Co. and Spectrum Pharmaceuticals. Please visit www.captisol.com for more information on Captisol and www.ligand.com for more information on Ligand.
Follow Ligand on Twitter @Ligand_LGND.
Source: Ligand Pharmaceuticals Incorporated
Released October 14, 2013